A randomised controlled trial of oral l-arginine supplementation on platelet and endothelial function and walking distance in patients with peripheral arterial disease

Mise à jour : Il y a 5 ans
Référence : EUCTR2006-001125-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary aims of proposed study: In patients with peripheral arterial disease, to assess the effects of L-arginine on 1) platelet activation and 2 ) endothelial activation as assessed by plasma markers vWF, sE-selectin and VCAM-1, and pulse wave velocity


Critère d'inclusion

  • Peripheral arterial disease

Liens